Bram Thijssen

1.3k total citations
24 papers, 825 citations indexed

About

Bram Thijssen is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bram Thijssen has authored 24 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bram Thijssen's work include Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Bioinformatics and Genomic Networks (3 papers). Bram Thijssen is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Bioinformatics and Genomic Networks (3 papers). Bram Thijssen collaborates with scholars based in Netherlands, United States and Belgium. Bram Thijssen's co-authors include Haiyuan Yu, Jishnu Das, Xiaomu Wei, Xiujuan Wang, Steven M. Lipkin, Lodewyk F.A. Wessels, René Bernards, Jeff Johnson, Ultan McDermott and Mathew J. Garnett and has published in prestigious journals such as Nature Biotechnology, Bioinformatics and Cancer Research.

In The Last Decade

Bram Thijssen

24 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bram Thijssen Netherlands 11 539 203 103 102 100 24 825
Sukjoon Yoon South Korea 21 702 1.3× 155 0.8× 111 1.1× 98 1.0× 50 0.5× 54 974
Eric Wen Su United States 12 779 1.4× 230 1.1× 61 0.6× 58 0.6× 151 1.5× 20 1.2k
Kevin Hudson United Kingdom 17 779 1.4× 223 1.1× 52 0.5× 71 0.7× 145 1.4× 30 1.1k
John M. Hatcher United States 16 574 1.1× 211 1.0× 38 0.4× 87 0.9× 98 1.0× 33 967
Ana Igea Spain 14 793 1.5× 260 1.3× 30 0.3× 69 0.7× 124 1.2× 25 1.1k
Christian Borgo Italy 18 702 1.3× 224 1.1× 51 0.5× 59 0.6× 86 0.9× 38 991
R.C. Hillig Germany 18 668 1.2× 123 0.6× 35 0.3× 75 0.7× 275 2.8× 32 1.0k
Vinothini Rajeeve United Kingdom 15 486 0.9× 146 0.7× 33 0.3× 59 0.6× 99 1.0× 37 823
Chris J. Novotny United States 9 642 1.2× 179 0.9× 39 0.4× 78 0.8× 61 0.6× 10 829
Qiaodan Zhou China 10 535 1.0× 132 0.7× 26 0.3× 45 0.4× 62 0.6× 21 815

Countries citing papers authored by Bram Thijssen

Since Specialization
Citations

This map shows the geographic impact of Bram Thijssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bram Thijssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bram Thijssen more than expected).

Fields of papers citing papers by Bram Thijssen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bram Thijssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bram Thijssen. The network helps show where Bram Thijssen may publish in the future.

Co-authorship network of co-authors of Bram Thijssen

This figure shows the co-authorship network connecting the top 25 collaborators of Bram Thijssen. A scholar is included among the top collaborators of Bram Thijssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bram Thijssen. Bram Thijssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liefaard, Marte C., Anna van der Voort, Maartje van Seijen, et al.. (2024). Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade. npj Breast Cancer. 10(1). 29–29. 10 indexed citations
2.
Steenbruggen, Tessa G., Denise M. Wolf, Bram Thijssen, et al.. (2023). Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort. JCO Precision Oncology. 7(7). e2200670–e2200670. 1 indexed citations
3.
Steenbruggen, Tessa G., Denise M. Wolf, Michael J. Campbell, et al.. (2023). B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer. Breast Cancer Research. 25(1). 117–117. 5 indexed citations
4.
Pogacar, Ziva, Fleur Jochems, Antonio Mulero‐Sánchez, et al.. (2022). Genetic and compound screens uncover factors modulating cancer cell response to indisulam. Life Science Alliance. 5(9). e202101348–e202101348. 8 indexed citations
5.
Thijssen, Bram, et al.. (2022). A highly sensitive bioanalytical method for the quantification of vinblastine, vincristine, vinorelbine and 4-O-deacetylvinorelbine in human plasma using LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 215. 114772–114772. 7 indexed citations
6.
Jochems, Fleur, Bram Thijssen, Giulia De Conti, et al.. (2021). The Cancer SENESCopedia: A delineation of cancer cell senescence. Cell Reports. 36(4). 109441–109441. 122 indexed citations
7.
Almekinders, Mathilde M., Michael Schaapveld, Bram Thijssen, et al.. (2021). Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ. npj Breast Cancer. 7(1). 31–31. 15 indexed citations
8.
Secades, Pablo, et al.. (2019). Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo. Breast Cancer Research. 21(1). 63–63. 18 indexed citations
9.
Huijberts, Sanne C.F.A., Emilie M.J. van Brummelen, Robin M.J.M. van Geel, et al.. (2019). Phase I study of lapatinib and trametinib in patients with KRAS mutant colorectal, non-small cell lung and pancreatic cancer. Annals of Oncology. 30. v178–v179. 2 indexed citations
10.
Jastrzebski, Katarzyna, Bram Thijssen, Roelof J.C. Kluin, et al.. (2018). Integrative Modeling Identifies Key Determinants of Inhibitor Sensitivity in Breast Cancer Cell Lines. Cancer Research. 78(15). 4396–4410. 12 indexed citations
11.
Verheijen, Remy B., Bram Thijssen, Florence Atrafi, et al.. (2018). Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling. Journal of Chromatography B. 1104. 234–239. 40 indexed citations
12.
Thijssen, Bram, M. J. X. Hillebrand, Hilde Rosing, et al.. (2017). Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of Dexamphetamine in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 148. 259–264. 3 indexed citations
13.
Thijssen, Bram, Tjeerd M. H. Dijkstra, Tom Heskes, & Lodewyk F.A. Wessels. (2017). Bayesian data integration for quantifying the contribution of diverse measurements to parameter estimates. Bioinformatics. 34(5). 803–811. 3 indexed citations
14.
Thijssen, Bram, Tjeerd M. H. Dijkstra, Tom Heskes, & Lodewyk F.A. Wessels. (2016). BCM: toolkit for Bayesian analysis of Computational Models using samplers. BMC Systems Biology. 10(1). 100–100. 8 indexed citations
15.
Johnson, Jeff, Bram Thijssen, Ultan McDermott, et al.. (2016). Targeting the RB-E2F pathway in breast cancer. Oncogene. 35(37). 4829–4835. 153 indexed citations
16.
Wang, Xiujuan, Bram Thijssen, & Haiyuan Yu. (2013). Target Essentiality and Centrality Characterize Drug Side Effects. PLoS Computational Biology. 9(7). e1003119–e1003119. 32 indexed citations
17.
Wang, Xiujuan, Xiaomu Wei, Bram Thijssen, et al.. (2012). Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nature Biotechnology. 30(2). 159–164. 289 indexed citations
18.
Dubbelman, Anne-Charlotte, Hilde Rosing, Bram Thijssen, et al.. (2012). Development and validation of LC–MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices. Journal of Chromatography B. 887-888. 25–34. 37 indexed citations
19.
Dubbelman, Anne-Charlotte, Hilde Rosing, Bram Thijssen, et al.. (2011). Validation of high-performance liquid chromatography–tandem mass spectrometry assays for the quantification of eribulin (E7389) in various biological matrices. Journal of Chromatography B. 879(15-16). 1149–1155. 9 indexed citations
20.
Veltkamp, Stephan A., Bram Thijssen, Jean‐Sébastien Garrigue, et al.. (2006). A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer. British Journal of Cancer. 95(6). 729–734. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sukjoon Yoon Breakdown of academic impact, for papers by Eric Wen Su Breakdown of academic impact, for papers by Kevin Hudson Breakdown of academic impact, for papers by John M. Hatcher Breakdown of academic impact, for papers by Ana Igea Breakdown of academic impact, for papers by Christian Borgo Breakdown of academic impact, for papers by R.C. Hillig Breakdown of academic impact, for papers by Vinothini Rajeeve Breakdown of academic impact, for papers by Chris J. Novotny Breakdown of academic impact, for papers by Qiaodan Zhou
Rankless by CCL
2026